Clinical Trial Update: Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial update comparing two NN1250 formulations in adults with Type 1 diabetes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED